Shares of Compass Therapeutics CMPX have skyrocketed 108.3% in a month after the company announced updates regarding its ...

Scientific Advisory Board formed with internationally recognized liver and biliary tract cancer physicians to support the advancement of ...

“This is the first precision medicine study for patients with cancer in the biliary tract and the first time this patient group will be offered these anti-cancer therapies. This is the first ...

Casdozokitug, in combination with atezolizumab/bevacizumab, final data demonstrate durability of response and improvement in depth of response including a 17.2% complete response rate – – Antitumor ...

Overall, the study aims to recruit 800 people from all over the world. Bile duct cancer (also called cholangiocarcinoma or ...

Biliary tract cancer (BTC), a rare malignancy that grows within the bile ducts and gallbladder, grows very aggressively.  The ...

A new clinical trial, sponsored by UCL and UCLH, aims to extend survival for some patients with cancer in the biliary tract by treating them with therapies specifically tailored to the genetic profile ...

The results of a clinical trial led by researchers at the University of Arizona Health Sciences and published in the Journal ...

"Biliary tract cancer is comparatively rare, but it's aggressive and spreads fast. Our accrual of more than 450 patients in a little more than two years really shows there is a need for new ways to ...

"Biliary tract cancer is comparatively rare, but it's aggressive and spreads fast. Our accrual of more than 450 patients in a little more than two years really shows there is a need for new ways ...

Its current publication date reflects a new medical review. “I’m sorry, but your breast cancer has spread to your liver.” These may be the words my oncologist used when he told me that I was ...